Must-read content in pharmacometrics

If you are unable to see the message below, click here to view.

Featured Content Original Articles A Mathematical Model for the Rational Design of Chimeric Ligands in Selective Drug Therapies V Doldán-Martelli, et al. Veritcal Integration of Pharmacogenetics in Population PK/PD Modeling: A Novel Information Theoretic Method J Knights, et al. Comparisons of Analysis Methods for Proof-of-Concept Trials K E Karlsson, et al. Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus H Naik, et al. e-alert Be part of it all CPT:PSP is the publication choice for papers targeted toward the pharmacometrics and systems pharmacology community. Interested in submitting? Visit our Benefits to Authors page for more information.

As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries. Nature Publishing Group | Principal offices: London | New York | Tokyo. Worldwide offices: Basingstoke | Boston | Buenos Aires | Delhi | Hong Kong | Madrid | Melbourne | Munich | Paris | San Francisco | Seoul | Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | 75 Varick St Fl 9 | New York | NY 10013-1917 | USA © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.